Angle PLC Announces HER2 Presentation at SABCS
WEILL CORNELL MEDICINE PRESENTS HER2 PARSORTIX WORKFLOW AT SAN ANTONIO BREAST CANCER SYMPOSIUMIndependent findings support ANGLE's HER2 assay development programmePotential...
Clinical Trial
Diverse Virus Populations Coexist on Single Strains of Gut Bacteria
Viral "Social Lives" Key to Developing Treatments for Bacterial Infections NEW YORK, Dec. 12, 2024 /PRNewswire/ -- Viruses that infect...
Health Union Earns 12 Digital Health Awards for Excellence in Patient Education and Support
Health Union earns Gold for "Patient Insider," its innovative patient influencer experience, as well as recognition for outstanding achievements in...
Aptevo Therapeutics Announces Exercise of Warrants for $6.2 Million Gross Proceeds
SEATTLE, WA / ACCESSWIRE / December 12, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology...
Robles BioCeutics CEO Maria Robles Named Finalist for San Diego Business Woman of the Year
Founder of First Senolytic Based Regenerative Dermatology Company to Honored for Contributions SAN DIEGO, Dec. 12, 2024 /PRNewswire/ -- Robles...
Coronado Research announce appointment of Dr. Jennifer Bradford as VP, Head of Data Science
LONDON, Dec. 12, 2024 /PRNewswire/ -- Coronado Research announced today that Dr. Jennifer Bradford has been appointed as VP, Head of...
Greenlight Health Data Solutions and Pattern Health Merge to Expand Healthcare, Life Sciences and Insurance Solutions
RALEIGH-DURHAM, N.C., Dec. 12, 2024 /PRNewswire/ -- Greenlight Health Data Solutions, a leading provider of seamless access to patient-consented medical...
DCN Dx Announces 2025 Basic Lateral Flow Training Course Dates
Industry-Leading Training on Lateral Flow Assay Development Returns with New Opportunities CARLSBAD, Calif., Dec. 12, 2024 /PRNewswire/ -- DCN Dx, specializing...
PhaseV to Present Novel Causal Machine Learning Method for Understanding Patient Treatment Response at ML4H Symposium
New Method, Applicable to Multiple Therapeutic Areas and Clinical Phases, Can Advance Precision Medicine for Improved Patient Outcomes BOSTON, Dec....
Phio Pharmaceuticals Announces Publication in Frontiers in Immunology
Journal is the official publication of the International Union of Immunological SocietiesMarlborough, Massachusetts--(Newsfile Corp. - December 12, 2024) - Phio...
Significant Positive Results with Jaguar Health’s Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients Presented at San Antonio Breast Cancer Symposium (SABCS)
Adult patients with breast cancer are a prespecified subgroup of the recently conducted phase 3 OnTarget trial evaluating crofelemer for...
100% of Patients Achieve Remission Within 30 Days in Cohort 1 of Bispecific Mipletamig Frontline AML Trial
Two of three patients achieved both complete remission and MRD-negative statusHigh response rates observed in earlier studies continue in ongoing...
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules
PALO ALTO, CA / ACCESSWIRE / December 12, 2024 / 180 Life Sciences Corp. ("180" or the "Company") is pleased...
AIM ImmunoTech Expands Patent Portfolio with New Netherlands Composition and Methods Patent Covering Ampligen for Use in the Post-COVID Condition of Fatigue
OCALA, Fla., Dec. 12, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that...
Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD
The milestone demonstrates AVISE CTD’s value and adoption within the rheumatologic community, clearly demonstrating superior laboratory testing for improved patient...
iTeos Therapeutics Presents Interim A2A-005 Clinical Trial Data, Translational, and Preclinical Data from Inupadenant at ESMO Immuno-Oncology Congress
- Inupadenant + carboplatin/pemetrexed in Phase 2 A2A-005 trial demonstrated a 63.9% overall response rate (ORR) and a median PFS...
Zymeworks Hosts R&D Day Highlighting Continued Clinical Progress in Oncology Programs and Expansion into Autoimmune and Inflammatory Diseases
Company on track to deliver five Investigational New Drug (IND) applications as part of ‘5 by 5’ solid tumor strategy...
Scilex Holding Company Announces $17 Million Registered Direct Offering
PALO ALTO, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative...
BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder
BURLINGTON, Mass. and JERUSALEM, Dec. 12, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced Melanoma
- IMM-1-104 has the potential to benefit melanoma patients who have progressed on or are intolerant to immune checkpoint inhibitors...